[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of T ârgu Mureș, Romania].

Conclusion: Our patients were on lower levodopa doses (compared to literature), but the combinations were used more often. Device-aided therapies should be considered in patients with severe motor complications who receive at least 750-1000 mg levodopa daily, divided minimum 5×/day. These patients need to be tested in specialized centers by multidisciplinary teams in order to make the best decision for further action. Orv Hetil. 2019; 160(17): 662-669.
PMID: 31010306 [PubMed - in process]

Source: Orvosi Hetilap - March 31, 2019 Category: General Medicine Authors: Szász JA, Szatmári S, Constantin V, Mihály I, Rácz A, Domokos LC, Vajda T, Orbán-Kis K Tags: Orv Hetil Source Type: research